Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 320,715 |
|
|||||
| News | - | ||||||
| Day High | 33.79 | Low High |
|||||
| Day Low | 32.96 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.21 | -0.63% | 33.11 | 14:53:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 33.28 | 32.96 | 33.79 | 33.32 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,716 | 320,715 | $ 33.31 | $ 10,681,528 | - | 12.35 - 34.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:53:20 | 1 | $ 33.1452 | USD |
Biohaven (BHVN) Options Flow Summary
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.66B | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biohaven News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 32.89 | 34.21 | 32.46 | 33.53 | 1,187,369 | 0.22 | 0.67% |
| 1 Month | 29.62 | 34.21 | 26.93 | 31.04 | 1,030,011 | 3.49 | 11.78% |
| 3 Months | 19.16 | 34.21 | 16.45 | 26.69 | 1,268,358 | 13.95 | 72.81% |
| 6 Months | 22.70 | 34.21 | 16.45 | 24.40 | 1,105,017 | 10.41 | 45.86% |
| 1 Year | 16.23 | 34.21 | 12.35 | 20.18 | 1,079,628 | 16.88 | 104.0% |
| 3 Years | 90.07 | 152.56 | 7.10 | 68.94 | 953,746 | -56.96 | -63.24% |
| 5 Years | 42.47 | 152.56 | 7.10 | 63.25 | 866,225 | -9.36 | -22.04% |
Biohaven Description
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |
